SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody ...
Gov. J.B. Pritzker wants to let Illinois companies sell their research and development tax credits to other businesses — a move biotech leaders say would funnel much-needed cash to startups and make ...
Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP ...
Secured $26 Million in PIPE Financing Led by a Top-Tier Biotech Investor to Advance Preclinical Programs and Extend Cash Runway Progressed Pipeline with New Preclinical Data and Scientific ...
Wall Street expects a year-over-year increase in earnings on lower revenues when iBio, Inc. (IBIO) reports results for the quarter ended December 2025. While this widely-known consensus outlook is ...
SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement ...
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in iBio, Inc.'s (NASDAQ:IBIO) case, it's fantastic news for shareholders. While ...
Strengthened cash position and extended runway into the fourth quarter of fiscal year 2027 after closing underwritten public offering with up to potentially $100 million of total gross proceeds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results